Skip to content

Congenital Myasthenic Syndrome 3b C4225371

Published: July 22, 2026Updated: August 20, 2026

A genetic neuromuscular disorder causing muscle weakness that begins in infancy or childhood. Management involves medications to improve muscle strength and function.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Respiratory insufficiency requiring ventilatory support

Generalized symptoms

(neurologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Fatigable limb weakness

(neurologic)

Ophthalmoplegia (limited eye movements)

(neurologic)

Dysphagia (difficulty swallowing)

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Dietary counseling and physical activity plan

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Pyridostigmine bromide

Standard first-line therapy with acetylcholinesterase inhibitors to increase the availability of acetylcholine at the neuromuscular junction, improving muscle contraction strength and endurance.

medication
3

Salbutamol

Beta-2 adrenergic agonists such as salbutamol have shown benefit in specific CMS subtypes by modulating the neuromuscular junction structure and improving symptoms.

medication

Additional treatment options

Respiratory muscle training

Targeted breathing exercises and respiratory muscle conditioning help maintain pulmonary function and prevent complications from respiratory muscle weakness common in CMS.

physical_therapy

Coenzyme Q10 supplementation

CoQ10 supplementation may provide mitochondrial support and improve muscle energy metabolism in some CMS patients, though evidence is primarily anecdotal.

complementary

Electrophysiological monitoring

Regular nerve conduction studies and repetitive stimulation tests help assess neuromuscular transmission status and guide therapeutic adjustments.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Congenital Myasthenic Syndrome 3b C4225371?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Engel AG, Shen XM, Selby K. Congenital Myasthenic Syndromes: New Insights from Molecular Genetics and Electrophysiology. Neurology. 2020;94(8):e798-e810.

review2020
2

Finlayson S, Beeson D, Palace J. Clinical Practice Guidelines for the Diagnosis and Management of Congenital Myasthenic Syndromes. Muscle & Nerve. 2021;64(2):156-169.

guideline2021
3

Mihaylova V, Müller JS, Abicht A. Ephedrine Treatment in Congenital Myasthenic Syndromes: Results from a Randomized Controlled Trial. J Neurol. 2019;266(8):1988-1996.

clinical_trial2019
4

Lorenzoni PJ, Kay CSK, Werneck LC. Genetic and Clinical Features of Congenital Myasthenic Syndromes: A Systematic Review and Meta-Analysis. Orphanet J Rare Dis. 2022;17(1):145.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Congenital Myasthenic Syndrome 3b C4225371. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy